Get 50% OFF This Monsoon!
Sarda Proteins
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
Sarda Proteins Ltd was incorporated in December 03, 1991. The company is mainly engaged in the distribution of refined oil, mustard oil and trading of Agro products like wheat, sesame seed, mustard seed, Guar seed and other edible products backed up with strong distribution network.
The company had an opening paid up capital as on 1st April 2015 Rs. 2,43,48,500. The company issued a final notice during the year 2015-16 to holders of 16,96,500 partly paid shares of Rs. 5 each, out of which company received calls for 1,39,300 shares only. Therefore as per the provisions of Articles of Association the 15,57,200 partly paid equity shares were forfeited and paid up capital stood at Rs. 1,72,59,000 comprising of 17,25,900 Equity Shares of Rs. 10 each and a balance of Rs. 77,86,000 in Share Forfeiture Account.
Ritika Vegetable Oil Private Limited, a company registered under the Companies Act, 1956 made a public announcement on April 03, 2019 to acquire 3,86,000 equity shares of Rs. 10/- each constituting 22.37% of the existing equity share capital along with Complete Control and Management of Sarda Proteins Ltd. Ritika Vegetable Oil Private Limited also filed a Detailed Public Statement on April 10, 2019. The Company had constituted a Committee of Independent Directors (IDC) in the interest of all stakeholders to provide their reasoned recommendation in respect of the offer by Ritika Vegetable Oil Private Limited. Further, the process of acquisition of the company has been completed in consonance with provisions of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and the post open offer report dated July 19, 2019 is duly submitted with the recognized Stock Exchanges and SEBI.
The Board of Directors at their meeting held on August 12, 2019 approved shifting of Registered Office of the Company from G-1-177 (A), Matsya Industrial Area, Alwar-301030 (Rajasthan) to B-536-537, Matsya Industrial Area, Alwar- 301030 (Rajasthan) which falls within the State of Rajasthan and within the same city.
Sarda Proteins share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Sarda Proteins indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Sarda Proteins is valued compared to its competitors.
Sarda Proteins PE ratio helps investors understand what is the market value of each stock compared to Sarda Proteins 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Sarda Proteins evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Sarda Proteins generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Sarda Proteins in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Sarda Proteins shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Sarda Proteins compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Sarda Proteins over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Sarda Proteins helps investors get an insight into when they can enter or exit the stock. Key components of Sarda Proteins Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Sarda Proteins shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Sarda Proteins ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Sarda Proteins provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Sarda Proteins highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Sarda Proteins .
The balance sheet presents a snapshot of Sarda Proteins ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.